Common Heart Failure With Preserved Ejection Fraction Animal Models Yield Disparate Myofibril Mechanics.
Jan 9, 2024DOI: 10.1161/jaha.123.032037Journal ArticleAHA
Written by: Axel J FenwickVivek P JaniD Brian FosterThomas E SharpTraci T GoodchildKyle LaPennaJake E DoironDavid J LeferJoseph A HillDavid A KassAnthony Cammarato
These studies were supported by National Institutes of Health (NIH) grant T32HL007227 and an American Heart Association/DC Women's Board grant 22POS915659 to Dr Fenwick; American Heart Association grant 23PRE1026275 and NIH grant F31HL168850 to V. P. Jani; NIH grant HL164478 to Dr Foster; NIH grant AA029984 to Dr Sharp; NIH grant HL159428 to Dr Goodchild; NIH grant TL1TR003106 to J. E. Doiron; NIH grants HL146098, HL146514, and HL151398 to Dr Lefer; NIH grants HL128215, HL147933, HL155765, and HL164586 to Dr Hill; NIH grants R35HL135827, R35HL166565, and support from Cytokinetics to Dr Kass; and NIH grant HL124091 to Dr Cammarato.
Disclosures
Dr Lefer is a consultant for Sulfagenix. Dr Kass receives research support from Amgen related to human heart failure with preserved ejection fraction studies. The remaining authors have no disclosures to report.
KL
Dr. Kyle LaPenna
Internal Medicine · Hospital MedicineNewYork–Presbyterian HospitalkylelNew York City, NY, USA